Alpha-1-antitrypsin (AAT), a well-characterized inhibitor of neutrophil serine protease, is used in augmentation therapy to treat emphysema due to severe AAT deficiency. Here, SERPINA1 is linked to alpha 1-antitrypsin deficiency.